Tvardi Therapeutics, Inc. (TVRD)
NASDAQ·Healthcare·Biotechnology
$2.70
+2.66%
Mkt Cap $37.34M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$3.00
Range $3.00 – $3.00
Implied Upside
+11.1%
Consensus $3.00 vs current $2.70
NASDAQ·Healthcare·Biotechnology
$2.70
+2.66%
Mkt Cap $37.34M
No recent rating data.
Price Target (5 analysts)
$3.00
Range $3.00 – $3.00
+11.1%
Consensus $3.00 vs current $2.70